市場調査レポート
商品コード
1158969
生物医学・ICTの融合市場:技術別、ソリューション別、地域別 (2022年~2027年)Biomedical and ICT Convergence Market by Technology, Solution and Region 2022 - 2027 |
生物医学・ICTの融合市場:技術別、ソリューション別、地域別 (2022年~2027年) |
出版日: 2022年11月22日
発行: Mind Commerce
ページ情報: 英文 138 Pages
納期: 即日から翌営業日
|
世界の生物医学ICT市場は2027年に730億米ドルに達する見通しです。地域別では、北米が今後のT市場をリードすると予測されています。セグメント別では、2027年にはハードウェア技術が生物医学ICT市場の52%以上を占めると見込まれています。活用領域別に見ると、診断・研究が主要なセグメントになると考えられています。今後は、生物医学とICTの融合が生物医学技術の優位性の基盤になるものと思われます。
生物医学とICTの融合は、医療とICTの両産業にとって大きな可能性を秘めた分野です。病気の治療や予防に加え、生物医学とICTの融合により、治療効果の向上や医療サービスの効率・効果の全体的な向上が期待されます。
医療におけるICTの最も成長著しい分野の一つは、IP対応・ハンドヘルド型デジタル機器による無線アクセスの利用です。ウェアラブルや埋め込み型技術は、健康科学の歴史において前例のないレベルのモニタリングや医療管理を約束するものです。治療管理から臨床意思決定支援まで、コネクテッドデバイスは医療実践の進歩のために急速に進化しているツールです。これらの同じツールは、インスリンの修正やワクチンの最適化など、リアクティブな医療様式とプロアクティブな医療様式の両方にそれぞれ使用される可能性があります。したがって、ICTと生物医学の融合は、経済性の向上(新しい医療治療の利用によるコスト削減・収益向上)と公衆衛生全体の向上につながると予想されます。
当レポートでは、世界の生物医学 (バイオメディカル) およびICT (情報通信技術) の融合に関する技術・市場動向について分析し、生物医学技術の概略・活用領域と関連分野、主要企業のプロファイル、全体的な市場規模の動向見通し (2022年~2027年)、セグメント別・地域別の詳細動向、関連市場の構造と動向、といった内容を取りまとめてお届けいたします。
This report evaluates the market for convergence between the Information and Communications Technology (ICT) industry and biomedical science and technologies. The report evaluates the latter and analyzes the former in terms of ICT innovation such as connected medical devices.
In addition to forecasts for IoT connected healthcare devices (standalone, wearable, and implantable), the report also assesses the outlook from 2022 to 2027 for various biomedical products, services, and solutions poised to benefit from various IT and telecom technologies.
The field of biomedicine is concerned with the application of various natural science disciplines for the development of knowledge, interventions, and/or technologies for use in healthcare. The Information and Communications Technology (ICT) sector focuses on telecommunications, computing, and the integration of both.
The convergence of biomedical and ICT represents a high opportunity area for both healthcare and ICT industries. In addition to seeking cures to disease and ailment prevention, combined biomedical and ICT solutions will lead to improved treatment efficacy as well as overall improvements in healthcare service delivery efficiency and effectiveness.
With healthcare costs growing much faster than the general inflation rate, it is of the utmost importance to simultaneously seek improved treatment while continuously driving down business costs. These costs include ongoing operational expenditures as well as expensive R&D such as drug discovery and other pharmaceutical-related areas such as vaccine development that takes into account precision medicine practices.
Various ICT tools may be employed such as IoT enabled monitoring to determine the effectiveness of medical procedures, which can be especially important when administering new and unproven healthcare modalities. One specific example is the administration of vaccines, which is believed to potentially cause harm to a subset of the population based on epigenetics, which is the study of changes in organisms caused by modification of gene expression rather than alteration of the genetic code itself.
This is believed to be an area in which a healthcare modality (in this example, vaccines) is designed with one intent (to inoculate one to prevent the onset of disease), but may actually trigger unintended consequences such as causing harm based on an individual's unique gene expression.
One of the fastest-growing areas for ICT in healthcare is the use of wireless access by IP-enabled, handheld digital devices. Wearables and implantable technology hold the promise of a level of monitoring and healthcare administration that is unprecedented in the history of health science. Ranging from treatment administration to clinical decision support, connected devices are a rapidly evolving tool for the advancement of healthcare practices.
These same tools may be used for both reactive and proactive medical modalities such as insulin modification and vaccine optimization respectively. The convergence of ICT and biomedicine is therefore anticipated to lead to both improved economics (lower costs and improved revenues through the identification of new healthcare treatments) as well as improve overall public health.
|
|